Drug and Alcohol Testing

In Minnesota, Adults 21 and older are permitted to use and possess up to two ounces of cannabis in public beginning August 1, 2023.

The Governor of Washington signed Senate Bill 5123 (SB 5123) into law this week, limiting employer rights to pre-employment testing for cannabis.

Learn about the DOT's approval of oral fluid drug testing, its impact on covered employees, and what it means for workplace compliance.

California has long been at the forefront of marijuana legalization in the United States. With the passing of AB 2188 in September of last year, employers must now navigate the complexities of this new legislation and its potential impact on their drug testing policies. 

Learn how Delaware’s recreational cannabis law impacts workplace drug testing, compliance policies, and employer responsibilities

Clear up misconceptions about cannabis and workplace drug testing. Learn the facts on compliance, impairment, and employer policies.

Explore the pros and cons of removing marijuana from drug testing panels and how it impacts workplace safety and employer compliance.

Learn how Kentucky’s medical cannabis legalization impacts drug testing policies, workplace safety, and employer compliance.

Discover Q4 2022 survey results on fentanyl concerns, drug testing gaps, and key compliance issues impacting industrial employers.

PHMSA reduces the minimum random drug testing rate to 25% for 2023. Learn how this change impacts employers and compliance programs.

Learn how Minnesota’s new regulations add oral fluid testing to workplace drug screening policies and impact employer compliance.

Learn how cannabis legalization in Maryland and Missouri affects employer drug testing policies, compliance, and workplace safety.